XML 72 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Payment (Details) - Schedule of Outstanding Options - 12 months ended Dec. 31, 2023
$ in Thousands
USD ($)
₪ / shares
Schedule of Outstanding Options [Line Items]    
Options outstanding 12,550,000  
December 30, 2014 [Member] | Four Directors [Member]    
Schedule of Outstanding Options [Line Items]    
Options outstanding 750,000  
Position Four Directors  
Grant date [1] December 30, 2014  
Fair value USD in thousands | $ $ 46  
Vesting schedule 33.33% of the stock options vest following the lapse of 12 months from the grant date, and the remaining 66.67% vest in 8 equal portions each quarter over a period of 2 years from the first  
December 30, 2014 [Member] | Four Directors [Member] | Bottom of range [member]    
Schedule of Outstanding Options [Line Items]    
Exercise price in NIS   ₪ 0.4325
December 30, 2014 [Member] | Four Directors [Member] | Top of range [member]    
Schedule of Outstanding Options [Line Items]    
Exercise price in NIS   0.4915
March 25, 2015 [Member] | One Director [Member]    
Schedule of Outstanding Options [Line Items]    
Options outstanding 150,000  
Position One Director  
Grant date [1] March 25, 2015  
Exercise price in NIS   0.4
Fair value USD in thousands | $ $ 24  
Vesting schedule 33.33% of the stock options vest following the lapse of 12 months from the grant date, and the remaining 66.67% vest in 8 equal portions each quarter over a period of 2 years from the first  
March 31, 2016 [Member] | Chairman of Board [Member]    
Schedule of Outstanding Options [Line Items]    
Options outstanding 1,500,000  
Position Chairman of Board  
Grant date [1] March 31, 2016  
Exercise price in NIS   0.6
Fair value USD in thousands | $ $ 63  
Vesting schedule 12 equal portions each quarter over a period of 3 years from the date of grant  
July 7, 2020 [Member] | Chief Executive Officer [Member]    
Schedule of Outstanding Options [Line Items]    
Options outstanding 10,000,000  
Position Chief Executive Officer  
Grant date [1] July 7, 2020  
Exercise price in NIS   0.09
Fair value USD in thousands | $ $ 103  
Vesting schedule 12 equal portions each quarter over a period of 3 years from the grant date  
March 2, 2023 [Member] | Director [Member]    
Schedule of Outstanding Options [Line Items]    
Options outstanding 150,000  
Position Director  
Grant date [1] March 2, 2023  
Exercise price in NIS   ₪ 0.0495
Fair value USD in thousands | $ $ 1  
Vesting schedule Fully vested on date of grant  
[1] Date of the Company's Board of Directors’ decision (or shareholders, if required). As of December 31, 2023, all options are vested and therefore there is no unrecognized compensation cost.